Both the immediate-release (IR) and extended-release (XR) versions of Adderall are classified as “Schedule II” controlled-substances.
I have idiopathic hypersomnia (a form of narcolepsy, extreme and constant sleepiness). I recently started taking off brand adderall (IR) and it is the only thing that makes me feel like I can function. I took 10mg tabs, one when I woke up, one at noon and one at four, 30 mg total. This kept me awake and feeling relatively normal.
A number of people do this and the only answer is to take meds 2x a day. Most docs prescribe a lower dose taken twice a day but still prescribe the EX. I’m not sure how I process this…do I process half in two hours and the other half two hours later? I just feel better on the IR, it’s released all at once and lasts 4-5 hours and then I take another one.
Many of the medications we take for our disorders come in immediate release or extended release forms. Immediate release, as the name.
Get every new post delivered to your Inbox.
Many of the medications we take for our disorders come in immediate release or extended release forms.
Good point Kitt, that makes total sense! I guess sleep and pain medication would be better as an immediate release formulation!
And now we know. Just found out: delayed release has a coating that stops it from being released too early in the digestive tract whereas extended release has a coating that slowly dissolves over 24 hours.
Notify me of new comments via.
You are commenting using your WordPress.com account.
Immediate-release products Extended-release drug products. drug concentration versus time profile and pharmacodynamic effect.
Targeted-release drug products. Targeted-release dosage forms may have either immediate- or extended-release characteristics. A dosage form that releases drug at or near the intended physiologic site of action (see Chapter 18 ).
24 Hour Subscription $34.95.
Otherwise it is hidden from view. Please Wait. This div only appears when the trigger link is hovered over.
A dosage form that releases a discrete portion or portions of drug at a time other than promptly after administration. An initial portion may be released promptly after administration.
FDA safety page: Delayed-release vs. extended-release Rxs in multiple product formulations—immediate-release, delayed-release, and.
Thus, when a patient was admitted taking Depakote ER 750 mg twice a day for seizure control, the pharmacy incorrectly dispensed Depakote delayed-release tablets. Another report, in 2005, documented hospital personnel crushing Depakote tablets prior to giving them to a patient. A 2006 medication error report documented the reporter, a pharmacist, using delayed-release and extended-release interchangeably. Also in 2006, FDA received a medication error report that documented a hospital pharmacy defining Depakote delayed-release tablets as the "twice-a-day" formulation, and Depakote ER as the "once-a-day" formulation.
It has been suggested that Controlled release be merged into this article. at less frequent intervals than immediate-release (IR) formulations of the same drug.
A few other abbreviations are similar to these (in that they may serve as suffixes) but refer to dose rather than release rate. They include ES and XS (extra strength).
Today, most time-release drugs are formulated so that the active ingredient is embedded in a matrix of insoluble substance(s) (various: some acrylics, even chitin ; these substances are often patented ) such that the dissolving drug must find its way out through the holes in the matrix. Some drugs are enclosed in polymer-based tablets with a laser-drilled hole on one side and a porous membrane on the other side.